An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder

Abstract Background Despite the current treatments available for panic disorder (PD), as many as one-third of patients have persistent and treatment-resistant panic attacks. Vortioxetine is an approved medicine for major depressive disorder and has been shown to have anxiolytic properties. The purpo...

Full description

Bibliographic Details

Published in:	Annals of General Psychiatry
Main Authors:	Anish Shah, Joanne Northcutt
Format:	Article
Language:	English
Published:	BMC 2018-05-01
Subjects:	Panic disorder Vortioxetine Anxiety Agoraphobia Depression
Online Access:	http://link.springer.com/article/10.1186/s12991-018-0190-6